Moderna, Inc. Common Stock vs. Scholar Rock Holding Corporation Common Stock
MRNA
Moderna, Inc. Common Stock
$194.82 +6.98%
VS SRRKScholar Rock Holding Corporation Common Stock
$49.85 -2.62%
Moderna, Inc. Common Stock (MRNA) comes out ahead, leading on 5 of 6 compared factors.
Size & Scale
| MRNA | SRRK | |
|---|---|---|
| Market Cap | $72.70 billion | $6.07 billion |
| Revenue (TTM) | $2.23 billion | — |
| Net Income (TTM) | $-3,151,000,000 | $-408,591,000 |
MRNA leads on 2 of 3 size & scale factors.
Valuation
| MRNA | SRRK | |
|---|---|---|
| Price / Book | 10.75 | 23.92 |
| Price / Sales | 32.63 | — |
MRNA leads on 1 of 1 valuation factors.
Profitability
| MRNA | SRRK | |
|---|---|---|
| Net Margin | -141.43% | — |
| Return on Equity | -46.61% | -161.00% |
MRNA leads on 1 of 1 profitability factors.
Risk & Sentiment
| MRNA | SRRK | |
|---|---|---|
| Short Interest | 0.01% | 0.11% |
MRNA leads on 1 of 1 risk & sentiment factors.
Dig deeper: MRNA overview, MRNA financials, SRRK overview, SRRK financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.